Close



Apr 17, 2024 07:00AM
Apr 15, 2024 07:00AM
Mar 25, 2024 06:45AM
Mar 18, 2024 07:00AM
Mar 14, 2024 06:02AM
Mar 14, 2024 06:00AM
Mar 5, 2024 07:00AM First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
Mar 4, 2024 08:06AM
Mar 4, 2024 08:00AM
Feb 13, 2024 07:00AM
Feb 13, 2024 07:00AM
Jan 23, 2024 07:00AM
Jan 17, 2024 07:00AM
Jan 4, 2024 06:01AM First Wave BioPharma (FWBI) CEO Issues Letter to Stockholders, Provides 2024 Outlook
Jan 4, 2024 06:00AM
Dec 27, 2023 11:55AM
Dec 27, 2023 11:55AM
Dec 27, 2023 06:56AM
Dec 27, 2023 06:00AM
Dec 18, 2023 06:01AM
Dec 18, 2023 06:00AM First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
Dec 14, 2023 09:15AM
Dec 14, 2023 09:15AM
Sep 15, 2023 08:45AM
Sep 14, 2023 10:45AM
Sep 14, 2023 10:43AM
Sep 14, 2023 06:00AM
Sep 14, 2023 06:00AM First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
Jul 19, 2023 08:17AM
Jul 19, 2023 08:15AM
Jul 13, 2023 07:01AM
Jul 13, 2023 07:00AM
Jul 5, 2023 07:00AM
Jul 5, 2023 07:00AM
Jun 28, 2023 07:00AM First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
Jun 27, 2023 07:01AM
Jun 27, 2023 07:00AM
Jun 15, 2023 11:31AM
Jun 13, 2023 12:51PM
Jun 13, 2023 12:50PM
Jun 13, 2023 07:36AM
Jun 13, 2023 07:00AM First Wave BioPharma Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis
May 15, 2023 07:00AM
May 11, 2023 07:00AM
May 2, 2023 07:30AM
Apr 25, 2023 07:00AM
Mar 13, 2023 08:00AM
Mar 10, 2023 07:00AM
Mar 9, 2023 07:34AM First Wave BioPharma (FWBI) dosed first patient in Phase 2 trial of adrulipase for EPI in CF
Mar 9, 2023 07:00AM

922,394 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All